AshutoshManojkumarShuklaMD

Nephrology • Gainesville, FL

Associate Professor, Medicine, University of Florida College of Medicine

Join to view full profile

Dr. Shukla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shukla's full profile

Already have an account?

Office
1600 Sw Archer Rd
Gainesville, FL 32610
Phone+1 352-273-9180

Education & Training

University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2006 - 2009
B. J. Medical College AhmedabadClass of 1996

Certifications & Licensure

FL State Medical License 2011 - 2027
AR State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Management of Cardiovascular Disease in Kidney Disease (MaCK) Study Start of enrollment: 2018 Dec 14
COMPLETED
PHASE2
Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans Start of enrollment: 2020 Mar 25
RECRUITING
NA

Publications & Presentations

PubMed

1 citations
Race- and Ethnicity-Related Disparities in Predialysis Nephrology Care, Kidney Disease Education, and Home Dialysis Utilization.
Ashutosh M Shukla, Grant Scheiffele, Wenxi Huang, Rebecca Campbell-Montalvo, Jiang Bian
Journal of the American Society of Nephrology. 2025-01-01
Hospitalization after hydroxychloroquine initiation in patients with heart failure with preserved ejection fraction and autoimmune disease.
Munaza Riaz, Haesuk Park, Carl J Pepine, Ashutosh M Shukla
Journal of Internal Medicine. 2024-11-01
Comparative Safety of Long-Acting vs. Short-Acting Erythropoiesis-Stimulating Agents Among Patients Undergoing Hemodialysis.
Raj Desai, Ikenna Unigwe, Munaza Riaz, Steven M Smith, Ashutosh M Shukla
Clinical Pharmacology and Therapeutics. 2024-07-01

Press Mentions

Home Dialysis, Insurance Trends Highlight Racial Disparities in ESKDOctober 7th, 2024
Repeated Covid Infections May Trigger More Health RisksApril 8th, 2023
Omicron Risk Triggering Long COVID Symptoms? Check Out the Symptoms According to ExpertsMarch 3rd, 2022
Join now to see all

Grant Support

A Patient-centered, System-based Approach to Improve Informed Dialysis Choice and Outcomes in Veterans with CKDVETERANS HEALTH ADMINISTRATION2020–2026
Hydroxychloroquine for the Management of CVD in CKDVETERANS HEALTH ADMINISTRATION2018–2025
Hydroxychloroquine for the Management of CVD in CKDVETERANS HEALTH ADMINISTRATION2018–2025